Cardiol Therapeutics, Inc. (CRDL)
1.12
-0.03
(-2.61%)
USD |
NASDAQ |
Oct 23, 16:00
1.12
0.00 (0.00%)
After-Hours: 20:00
Cardiol Therapeutics Net Income (Quarterly) : -4.393M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.393M |
| March 31, 2026 | -7.887M |
| December 31, 2025 | -5.173M |
| September 30, 2025 | -7.236M |
| June 30, 2025 | -6.033M |
| March 31, 2025 | -5.776M |
| December 31, 2024 | -5.848M |
| September 30, 2024 | -9.332M |
| June 30, 2024 | -4.817M |
| March 31, 2024 | -6.807M |
| December 31, 2023 | -5.607M |
| September 30, 2023 | -4.421M |
| June 30, 2023 | -5.563M |
| March 31, 2023 | -5.242M |
| December 31, 2022 | -5.536M |
| September 30, 2022 | -6.104M |
| June 30, 2022 | -5.082M |
| March 31, 2022 | -7.069M |
| December 31, 2021 | -4.964M |
| Date | Value |
|---|---|
| September 30, 2021 | -7.865M |
| June 30, 2021 | -5.344M |
| March 31, 2021 | -7.036M |
| December 31, 2020 | -7.418M |
| September 30, 2020 | -3.303M |
| June 30, 2020 | -2.616M |
| March 31, 2020 | -2.192M |
| December 31, 2019 | -2.317M |
| September 30, 2019 | -2.644M |
| June 30, 2019 | -2.723M |
| March 31, 2019 | -2.626M |
| December 31, 2018 | -8.572M |
| September 30, 2018 | -3.756M |
| June 30, 2018 | -1.052M |
| March 31, 2018 | -0.4361M |
| December 31, 2017 | -0.4782M |
| September 30, 2017 | -0.4117M |
| June 30, 2017 | -0.3291M |
| March 31, 2017 | -0.0713M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -4.843M |
| NervGen Pharma Corp. | 7.803M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
| Appili Therapeutics, Inc. | -1.228M |
| Clearmind Medicine, Inc. | -0.9073M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.393M |
| EPS Diluted (Quarterly) | -0.0382 |
| Enterprise Value | 111.48M |
| Earnings Yield | -22.11% |
| Normalized Earnings Yield | -22.35 |